Efficacy and Safety of Qili Qiangxin Capsule on Dilated Cardiomyopathy: A Systematic Review and Meta-Analysis of 35 Randomized Controlled Trials

Objective: Qili Qiangxin Capsule (QQC), a Chinese patent medicine, is clinically effective in treating dilated cardiomyopathy (DCM). However, the meta-analysis of QCC combined with conventional western medicine (CWM) on DCM remains unexplored. This study aimed to systematically evaluate the efficacy...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jingjing Wei, Bin Li, Xinlu Wang, Xingyuan Li, Yucai Hu, Lijie Qiao, Cheng Zhou, Peng Yu, Tianqing Sang, Mingjun Zhu, Yongxia Wang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-04-01
Colecção:	Frontiers in Pharmacology
Assuntos:	Qili Qiangxin capsule dilated cardiomyopathy randomized controlled trials meta-analysis grade
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2022.893602/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!